Keywords: positive, ph, ii, data, schering, ag, zevalin

Positive Ph II data for Schering AG's Zevalin

Article | 20 June 2005

Print This

Results from a Phase II trial presented at the 9th International Congress on Malignant Lymphoma, held in Lugano, Switzerland, offer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in